Products

Dealspipeline

AI-native

Stop searching for deals. Start closing them.

dealspipeline.co Sales / Lead Databases & Enrichment

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$99/mo
Higher than 83% of peersNiche median $29/mo
Launched
7mo ago
2026-04-30 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Turn your ideal client into a pipeline of real deals 💰

    Apr 30 · 7mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-04-10

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Entry
Free
Up to 10 leads
Core
$99/mo
Unlimited leads
Pro
$299/mo
Concierge 💥
Unknown

Trial: None · 2 paid tiers ($99–$299) · Observed 2026-11-06 · Source page

Entry price $99/mo, Higher than 83% of peers; “Lead Databases & Enrichment” median is $29/mo.View pricing benchmark

Website snapshots

Indexed 2026-04-30

Key pages

Desktop & mobile archive
Home
dealspipeline.co/ Snapshot 2026-11-07

Questions & evidence

How much does Dealspipeline cost?
Entry: Free; Core: $99/mo; Pro: $299/mo; Concierge 💥: Unknown. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Dealspipeline get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Dealspipeline and what platforms does it support?
Dealspipeline is catalogued under Lead Databases & Enrichment: Stop searching for deals. Start closing them. Supported platforms: Web.

Related products in this category

Sales / Lead Databases & Enrichment

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.